UNH vs CVS
UnitedHealth Group Incorporated vs CVS Health Corp. · Updated Aug 11, 2026
UNH — 16 winsCVS — 7 wins
Price Performance
UNH +61.96%CVS +47.46%
Performance
| UNH | CVS | |
|---|---|---|
| 1 Month | -3.90% | -8.17% |
| 3 Months | +7.39% | +5.63% |
| 6 Months | +51.95% | +22.07% |
| YTD | +23.61% | +20.52% |
| 1 Year | +66.03% | +50.43% |
| 3 Year | -12.54% | +28.04% |
| 5 Year | +15.14% | +34.71% |
Yearly Returns
| YTD | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| UNH | +21.5% | -35.6% | -6.2% | +1.5% | +5.5% | +43.7% | +19.9% | +20.7% | +12.6% | +36.5% | +37.4% | +16.7% |
| CVS | +19.4% | +79.5% | -44.5% | -15.0% | -10.5% | +48.1% | -7.9% | +13.3% | -10.9% | -9.8% | -18.2% | +2.8% |
Valuation
| UNH | CVS | |
|---|---|---|
| P/E Ratio | 30.82 | 42.13 |
| Forward P/E | 9.99 | 12.51 |
| PEG Ratio | 2.08 | 2.38 |
| P/S Ratio | 0.82 | 0.30 |
| P/B Ratio | 3.56 | 1.58 |
| EV/EBITDA | 18.25 | 17.15 |
Financials
| UNH | CVS | |
|---|---|---|
| EPS (TTM) | $13.24 | $2.27 |
| Gross Margin | +22.74% | +15.56% |
| Operating Margin | +8.05% | +4.66% |
| Net Margin | +5.62% | +2.93% |
| ROE | +11.59% | +3.79% |
| ROA | +3.85% | +1.16% |
| Debt/Equity | 0.75 | 1.01 |
Growth
| UNH | CVS | |
|---|---|---|
| Revenue Growth YoY | +1.96% | +6.17% |
| Revenue Growth QoQ | -1.32% | -4.98% |
| EPS Growth YoY | +0.73% | +63.12% |
| EPS Growth QoQ | +62627.30% | 0.00% |
Technical
| UNH | CVS | |
|---|---|---|
| RSI (14) | 44.22 | 30.34 |
| % From 20-Day SMA | -2.67% | -8.71% |
| % From 50-Day SMA | -1.27% | -6.16% |
| % From 200-Day SMA | +17.75% | +12.38% |
| % From 52-Week High | -11.60% | -13.58% |
| % From 52-Week Low | +70.38% | +51.10% |
Analyst Ratings
UNH
Buy(42 analysts)
Strong SellHoldStrong Buy
Price Target
$473.89
+15.92% upside
CVS
Buy(24 analysts)
Strong SellHoldStrong Buy
Price Target
$110.21
+15.50% upside
Overview
| UNH | CVS | |
|---|---|---|
| Sector | Healthcare | Healthcare |
| Industry | Medical - Healthcare Plans | Medical - Healthcare Plans |
| Exchange | NYSE | NYSE |
| Market Cap | $369.69B | $122.11B |
| Shares Outstanding | 908.1M | 1.28B |
| Avg Volume (10D) | 4.51M | 9.02M |
| Dividend Yield | 2.20% | 2.78% |
Frequently Asked Questions
Is UNH or CVS a better buy right now?
Based on 23 comparable metrics, UNH leads in 16 categories while CVS leads in 7. UNH has a consensus analyst rating with 42 analysts covering the stock. Neither stock should be purchased based on a single comparison — consider your investment goals and risk tolerance.
Which stock has better performance, UNH or CVS?
Over the past year, UNH returned +66.03% compared to CVS's +50.43%. In the short term (1 month), UNH returned -3.90% vs CVS's -8.17%.
Is UNH or CVS more expensive?
UNH trades at a P/E of 30.82 compared to CVS's 42.13. On a price-to-sales basis, UNH trades at 0.82x vs CVS's 0.30x. Forward P/E: UNH at 9.99 vs CVS at 12.51.
Which stock has higher growth, UNH or CVS?
UNH's revenue grew +1.96% year-over-year compared to CVS's +6.17%. EPS growth: UNH at +0.73% vs CVS at +63.12%.
Do UNH and CVS pay dividends?
UNH pays a dividend with a yield of 2.20%. CVS pays a dividend with a yield of 2.78%.
Which stock do analysts prefer, UNH or CVS?
UNH has 42 analysts with a target price of $473.89 (+15.92% upside). CVS has 24 analysts with a target of $110.21 (+15.50% upside).
Data updated daily. All comparisons based on latest available market data. Not investment advice.